| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0003 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 0.0006 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0006 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0006 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |